| Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy C Berlin, DJ Kowalewski, H Schuster, N Mirza, S Walz, M Handel, ... Leukemia 29 (3), 647-659, 2015 | 163 | 2015 |
| Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer G Vandekerkhove, JM Lavoie, M Annala, AJ Murtha, N Sundahl, S Walz, ... Nature Communications 12 (1), 184, 2021 | 126 | 2021 |
| The antigenic landscape of multiple myeloma: mass spectrometry (re) defines targets for T-cell–based immunotherapy S Walz, JS Stickel, DJ Kowalewski, H Schuster, K Weisel, L Backert, ... Blood, The Journal of the American Society of Hematology 126 (10), 1203-1213, 2015 | 125 | 2015 |
| Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers HG Rammensee, J Stickel, D Kowalewski, S Stevanovic, S Walz US Patent 10,196,422, 2019 | 31 | 2019 |
| Expression of tumour progression‐associated genes in circulating tumour cells of patients at different stages of prostate cancer GI Russo, S Bier, J Hennenlotter, G Beger, L Pavlenco, J van de Flierdt, ... BJU international 122 (1), 152-159, 2018 | 29 | 2018 |
| Enfortumab vedotin–next game-changer in urothelial cancer M Maas, V Stühler, S Walz, A Stenzl, J Bedke Expert Opinion on Biological Therapy 21 (7), 801-809, 2021 | 28 | 2021 |
| Performance of urinary markers for detection of upper tract urothelial carcinoma: is upper tract urine more accurate than urine from the bladder? S Bier, J Hennenlotter, M Esser, S Mohrhardt, S Rausch, C Schwentner, ... Disease Markers 2018 (1), 5823870, 2018 | 24 | 2018 |
| Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini DJ Kowalewski, S Walz, L Backert, H Schuster, O Kohlbacher, K Weisel, ... Blood Cancer Journal 6 (4), e411-e411, 2016 | 23 | 2016 |
| Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma T Bilich, A Nelde, J Bauer, S Walz, M Roerden, HR Salih, K Weisel, ... Blood cancer journal 10 (2), 24, 2020 | 19 | 2020 |
| Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer M Hegemann, M Maas, S Rausch, S Walz, J Bedke, A Stenzl, ... Asian Journal of Andrology 21 (1), 12-18, 2019 | 18 | 2019 |
| Stress urinary incontinence: An unsolved clinical challenge N Harland, S Walz, D Eberli, FA Schmid, WK Aicher, A Stenzl, B Amend Biomedicines 11 (9), 2486, 2023 | 17 | 2023 |
| Bone health issues in patients with prostate cancer: an evidence-based review S Walz, M Maas, A Stenzl, T Todenhöfer The World Journal of Men's Health 38 (2), 151, 2020 | 15 | 2020 |
| A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens L Backert, DJ Kowalewski, S Walz, H Schuster, C Berlin, MC Neidert, ... Oncotarget 8 (27), 43915, 2017 | 14 | 2017 |
| Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer M Maas, S Walz, V Stühler, S Aufderklamm, S Rausch, J Bedke, A Stenzl, ... Expert Review of Molecular Diagnostics 18 (5), 443-455, 2018 | 13 | 2018 |
| Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers HG Rammensee, J Stickel, DJ Kowalewski, S Stevanovic, S Walz US Patent 10,377,797, 2019 | 11 | 2019 |
| Erratum: Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy C Berlin, DJ Kowalewski, H Schuster, N Mirza, S Walz, M Handel, ... Leukemia 30 (4), 1003-1004, 2016 | 11 | 2016 |
| A protocol for organoids from the urine of bladder cancer patients S Walz, P Pollehne, R Geng, J Schneider, M Maas, WK Aicher, A Stenzl, ... Cells 12 (17), 2188, 2023 | 10 | 2023 |
| Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies V Stühler, L Herrmann, M Maas, S Walz, S Rausch, A Stenzl, J Bedke World Journal of Urology 40 (5), 1175-1183, 2022 | 10 | 2022 |
| Enhancing tissue impedance measurements through modeling of fluid flow during viscoelastic relaxation C Veil, D Müller, S Walz, J Schüle, P Somers, C Tarín, A Stenzl, ... IEEE Transactions on Biomedical Engineering 70 (2), 650-658, 2022 | 8 | 2022 |
| Robotic radical cystectomy–more precision needed? S Walz, V Aslani, O Sawodny, A Stenzl Current opinion in urology 33 (2), 157-162, 2023 | 7 | 2023 |
